Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.
Bhatia, Smita
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. [electronic resource] - Blood Jan 2007 - 46-51 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
0006-4971
10.1182/blood-2006-01-023101 doi
Acute Disease
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Neoplasms--drug therapy
Child
Child, Preschool
Cyclophosphamide--administration & dosage
Dactinomycin--administration & dosage
Doxorubicin--administration & dosage
Etoposide--administration & dosage
Female
Follow-Up Studies
Humans
Ifosfamide--administration & dosage
Incidence
Infant
Leukemia, Myeloid--chemically induced
Male
Neoplasms, Second Primary--chemically induced
Neural Tube Defects--chemically induced
Neuroectodermal Tumors, Primitive--drug therapy
Proportional Hazards Models
Risk
Sarcoma, Ewing--drug therapy
Vincristine--administration & dosage
Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group. [electronic resource] - Blood Jan 2007 - 46-51 p. digital
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
0006-4971
10.1182/blood-2006-01-023101 doi
Acute Disease
Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Bone Neoplasms--drug therapy
Child
Child, Preschool
Cyclophosphamide--administration & dosage
Dactinomycin--administration & dosage
Doxorubicin--administration & dosage
Etoposide--administration & dosage
Female
Follow-Up Studies
Humans
Ifosfamide--administration & dosage
Incidence
Infant
Leukemia, Myeloid--chemically induced
Male
Neoplasms, Second Primary--chemically induced
Neural Tube Defects--chemically induced
Neuroectodermal Tumors, Primitive--drug therapy
Proportional Hazards Models
Risk
Sarcoma, Ewing--drug therapy
Vincristine--administration & dosage